Anzeige
Mehr »
Login
Donnerstag, 18.04.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Ausbruch – startet jetzt die massive FDA-Rallye?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1W7Q9 | ISIN: BE0974260896 | Ticker-Symbol: 1C0
Frankfurt
17.04.24
08:08 Uhr
0,299 Euro
+0,006
+1,88 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
CELYAD ONCOLOGY SA Chart 1 Jahr
5-Tage-Chart
CELYAD ONCOLOGY SA 5-Tage-Chart
RealtimeGeldBriefZeit
0,1530,49417.04.

Aktuelle News zur CELYAD ONCOLOGY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
04.04.Celyad Oncology SA reports FY results1
04.04.Celyad Oncology SA: Celyad Oncology Reports Full Year 2023 Financial Results and Recent Business Highlights371Regulatory News: Celyad Oncology (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (the "Company"), today announces its financial results for the fiscal year 2023 ended December 31, 2023, and provides...
► Artikel lesen
04.04.Celyad Oncology Reports Full Year 2023 Financial Results and Recent Business Highlights55MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Regulatory News: Celyad Oncology (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (the "Company"), today announces its financial results for the fiscal...
► Artikel lesen
08.02.Celyad Oncology SA: Celyad Oncology Announces Intention to Terminate SEC Reporting Obligations322Regulatory News: Celyad Oncology SA (Euronext: CYAD) ("Celyad Oncology" or the "Company") announces that it will voluntarily file a Form 15F with the United States Securities and Exchange Commission...
► Artikel lesen
17.01.Celyad Oncology SA - 6-K, Report of foreign issuer2
16.01.Celyad Oncology Provides Fourth Quarter 2023 Business Update and 2024 Outlook354Three main pillars to unlock the potential of proprietary technology platforms and intellectual property: A proprietary non-gene editing technology platform based on multiplexing of short hairpin...
► Artikel lesen
16.01.Celyad Oncology SA: Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook266Three main pillars to unlock the potential of proprietary technology platforms and intellectual property: A proprietary non-gene editing technology platform based on multiplexing of short hairpin...
► Artikel lesen
20.12.23Celyad Oncology SA: Publication of a Transparency Notification Received From Fortress Investment Group LLC421(Article 14 §1 of the Law of 2 May 2007) Regulatory News: Celyad Oncology SA (Euronext: CYAD) ("Celyad Oncology" or the "Company") (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) today announces...
► Artikel lesen
18.12.23Celyad Oncology SA - 6-K, Report of foreign issuer2
15.12.23Celyad Oncology SA: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)3
15.12.23Celyad Oncology SA: Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)479Regulatory News: Celyad Oncology (Euronext: CYAD) (the "Company" or "Celyad Oncology"), today announces that 6,500,000 shares of CFIP CLYD (UK) Limited benefit from a double voting right as of...
► Artikel lesen
04.12.23Celyad Oncology SA - 6-K, Report of foreign issuer1
04.12.23Celyad Oncology SA: Celyad Announces Management Change293Regulatory News: Celyad Oncology (Euronext: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a cutting-edge biotechnology company dedicated to pioneering the discovery and advancement of revolutionary...
► Artikel lesen
30.11.23Celyad Oncology SA: Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)359Regulatory News: Celyad Oncology SA (Euronext: CYAD) ("Celyad Oncology" or the "Company") today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication...
► Artikel lesen
24.11.23Celyad Oncology SA - 6-K, Report of foreign issuer1
21.11.23Celyad Oncology SA: Publication of a transparency notification received from Fortress Investment Group LLC402(Article 14 §1 of the Law of 2 May 2007) Regulatory News: Celyad Oncology SA (Euronext: CYAD) ("Celyad Oncology" or the "Company") today announced, in accordance with Article 14 of the Belgian...
► Artikel lesen
15.11.23Celyad Oncology SA - 6-K, Report of foreign issuer1
14.11.23Celyad Oncology SA: Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)320Regulatory News: Celyad Oncology (Euronext: CYAD) (the "Company" or "Celyad Oncology") (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), today announces the below information following the issuance,...
► Artikel lesen
14.11.23Celyad Oncology SA: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)2
09.11.23Celyad Oncology SA reports Q3 results1
Seite:  Weiter >>
35 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1